Evidence map›Paper›PMID 35702866›Full record

Trial reportJournal of the Royal Society, Interface2022

Modelling methicillin-resistant

Onur Poyraz, Mohamad R A Sater, Loren G Miller, James A McKinnell, Susan S Huang, Yonatan H Grad, Pekka Marttinen

Open access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of the Royal Society, Interface, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Modelling methicillin-resistantJournal of the Royal Society, Interface · 2022
    Trial
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Onur PoyrazDepartment of Computer Science, Aalto University School of Science, Aalto, Finland.ORCID 0000-0002-8257-2250
Mohamad R A SaterDepartment of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA, USA.ORCID 0000-0003-1912-0590
Loren G MillerDivision of Infectious Diseases, Lundquist Institute at Harbor-UCLA Medical Center, Los Angeles, CA, USA.
James A McKinnellDivision of Infectious Diseases, Lundquist Institute at Harbor-UCLA Medical Center, Los Angeles, CA, USA.
Susan S HuangDivision of Infectious Diseases, University of California Irvine School of Medicine, Irvine, CA, USA.
Yonatan H GradDepartment of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA, USA.ORCID 0000-0001-5646-1314
Pekka MarttinenDepartment of Computer Science, Aalto University School of Science, Aalto, Finland.ORCID 0000-0001-7078-7927
Aalto University · FIHarvard University · USUCLA Medical Center · USUniversity of California, Irvine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methicillin-resistant

Indexed as

Anti-Infective Agents, LocalMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsCarrier StateHumansMupirocinAnti-Bacterial AgentsAnti-Infective Agents, LocalMupirocincoupled hidden Markov modeldecolonization protocolmachine learningMarkov chain Monte Carlomethicillin-resistant Staphylococcus aureus

Identifiers

PMID35702866
PMCPMC9198502
OpenAlexW4282958535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.